WHAYN

Gurugram, India Founded: 2011 • Age: 15 yrs
Platform for healthcare product manufacturing, sourcing, and supply chain support.

About WHAYN

WHAYN is a Healthcare company based in Gurugram (India) founded in 2011. Platform for healthcare product manufacturing, sourcing, and supply chain support. It operates on a B2B Marketplace and Contract Manufacturing model in Healthcare and Industrial Goods & Manufacturing sectors. Its Indian entity Jindal Biotech Private Limited reported revenue of β‚Ή2.33 Cr. WHAYN offers products and services including Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing. Its focus areas include Pharmaceuticals, Supply Chain, White Label Production and Medical Devices. Its competitors include Medikabazaar and Aknamed; 2 of its 2 listed competitors have raised funding.

Company details

WHAYN is a platform that offers end-to-end solutions for developing, manufacturing, and complying with medical, pharmaceutical, and surgical products. It connects buyers and suppliers, providing features like batch tracking and regulatory assistance. Based in Menlo Park, USA, it serves brands and retailers worldwide, ensuring quality control and efficient scaling across various categories such as cotton products and wound care.

Key Metrics
  • Annual Revenue
    ₹2.33 Cr

    FY 2024 · -70% YoY

  • Net Loss
    -₹16.1 Lakh

    FY 2024 · -7% margin

  • EBITDA
    ₹2.1 Lakh

    FY 2024 · 1% margin

Products & Services of WHAYN

WHAYN offers a comprehensive portfolio of products and services, including Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing.

Contract Manufacturing
Manufacturing Services

Designs and produces custom products for clients.

Product Design and Development
Design Services

Develops original products for manufacturing.

White Labelled Manufacturing
OEM Services

Manufactures generic products under client brands.

Board of directors of Jindal Biotech Private Limited (WHAYN)

Jindal Biotech Private Limited is the primary company behind WHAYN. The board of Jindal Biotech Private Limited currently have 2 directors; the longest-serving is Rakesh Kumar Jindal, appointed in 2011. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rakesh Kumar Jindal
DIN 03285251
Director28 Jun 201115 yrs 4 moJindal Biotech Private Limited
Krishan Gopal
DIN 03285287
Director16 Aug 20224 yrs 3 moJindal Biotech Private Limited

Financials of WHAYN

Figures of Jindal Biotech Private Limited, the primary company behind WHAYN, for FY 2024. Revenue was ₹2.33 Cr (-70% year on year). Net loss was -₹16.1 Lakh (-7% margin). EBITDA was ₹2.1 Lakh (1% margin). Revenue has grown at a compounded annual rate of -34% over three years and -13% over five years.

  • ₹2.33 CrRevenue · FY 2024 · -70% YoY
  • -₹16.1 LakhNet loss · -7% margin
  • ₹2.1 LakhEBITDA · 1% margin
  • ₹25 LakhPaid-up capital
  • -34%Revenue CAGR, 3 years
  • -13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Jindal Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for WHAYN

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of WHAYN

WHAYN has 2 listed competitors in our database, 2 of them funded. They include Medikabazaar and Aknamed.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medikabazaar.com2014Mumbai, India$184.89M547
Online marketplace for medical supplies, equipment, and devices catering to healthcare providers
aknamed.com2018Gurugram, India$21.85M246
Cloud and AI-based material management software for hospitals is offered.
Premium access

Detailed competitors of WHAYN

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about WHAYN

WHAYN was founded in 2011.

WHAYN is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

The primary company behind WHAYN, Jindal Biotech Private Limited, reported revenue of β‚Ή2.33 Cr for FY 2024, down 70% year on year.

WHAYN is a platform that offers end-to-end solutions for developing, manufacturing, and complying with medical, pharmaceutical, and surgical products. It connects buyers and suppliers, providing features like batch tracking and regulatory assistance. Based in Menlo Park, USA, it serves brands and retailers worldwide, ensuring quality control and efficient scaling across various categories such as cotton products and wound care.

WHAYN's top competitors include Medikabazaar and Aknamed.

WHAYN offers Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing.

WHAYN operates through Jindal Biotech Private Limited.

The legal entities of WHAYN currently have 2 directors, including Rakesh Kumar Jindal, Krishan Gopal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available